EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fibromyalgia and menopause: Friends with benefits?

Arriana Gkouvi, Katerina-Maria Kontouli, Eleni C Pardali, Eleni Patrikiou, Irene Lambrinoudaki, Dimitrios G Goulis, Dimitrios P Bogdanos, Maria G Grammatikopoulou

Maturitas · 2026-05 · 208 · 108899

DOI: 10.1016/j.maturitas.2026.108899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Maturitas, 2026-05. Verfasst von Arriana Gkouvi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, Larissa University Hospital, University of Thessa…. Hauptthemen laut MEDLINE: Fibromyalgia, Menopause. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Fibromyalgia and menopause often share common symptomatology, including musculoskeletal pain, fatigue, brain fog and sleep disturbances. The menopausal transition can represent a critical time at which fibromyalgia symptoms often worsen. This study examined the relationship between fibromyalgia and menopause using validated instruments. METHODS: The Revised Fibromyalgia Impact Questionnaire (FIQR) was administered to 169 patients with fibromyalgia, and sociodemographic data and data on medication use were collected. Menopausal status was recorded, and the Greene Climacteric Scale (GCS) was administered. Linear regression analyses were performed to identify the predictors of more severe fibromyalgia impact and worse climacteric symptoms. RESULTS: Participants' mean age was 49.3 ± 9.6 years. Treatments for fibromyalgia included antidepressants (42.0% daily use), paracetamol, nonsteroidal anti-inflammatory drugs, and dietary supplements. Among the peri-/post-menopausal women, 6.25% were on hormone replacement therapy (HRT). The FIQR score was a significant predictor of the severity of menopausal symptoms (β = 0.38, 95% CI 0.26-0.51, p < 0.001), indicating that individuals with worse fibromyalgia tended to experience aggravated menopause symptomatology. Additionally, higher body mass index (BMI) was significantly associated with greater GCS scores (β = 0.84, 95% CI 0.35-1.33, p = 0.001) and more severe fibromyalgia impact (β = 1.1, 95% CI 0.61-1.57, p < 0.001, R2 = 0.11). Fibromyalgia preceded menopause in 51.0% of the sample and occurred concurrently in 21.9% of the sample. CONCLUSIONS: The findings suggest that fibromyalgia and menopausal symptoms overlap, worsening the symptom burden for patients in menopause. Higher FIQR scores were observed among patients with a greater BMI, indicating a greater overall disease impact and poorer quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibromyalgiaMenopauseHumansFemaleMiddle AgedBody Mass IndexSurveys and QuestionnairesSeverity of Illness IndexAdultAntidepressive AgentsHot FlashesAnti-Inflammatory Agents, Non-SteroidalDietary SupplementsFatigueSymptom Burden

Stichwörter der Autor:innen

AgingAnxietyEstrogenHot flashesMenopausalPainVasomotor symptoms

Substanzen

Antidepressive AgentsAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, Larissa University Hospital, University of Thessaly, Biopolis, Larissa, Greece.
  • Department of Primary Education, School of Education, University of Ioannina, Ioannina, Greece.
  • 2nd Department of Obstetrics and Gynecology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, Larissa University Hospital, University of Thessaly, Biopolis, Larissa, Greece; Unit of Reproductive Endocrinology, Fir…

Zitieren

APA

Gkouvi, A., Kontouli, K. M., Pardali, E. C., Patrikiou, E., Lambrinoudaki, I., Goulis, D. G., Bogdanos, D. P., & Grammatikopoulou, M. G. (2026). Fibromyalgia and menopause: Friends with benefits?. Maturitas, 208, 108899. https://doi.org/10.1016/j.maturitas.2026.108899

Vancouver

Gkouvi A, Kontouli KM, Pardali EC, Patrikiou E, Lambrinoudaki I, Goulis DG, et al. Fibromyalgia and menopause: Friends with benefits?. Maturitas. 2026;208:108899. doi:10.1016/j.maturitas.2026.108899

BibTeX
@article{Gkouvi2026,
  author = {Gkouvi, Arriana and Kontouli, Katerina-Maria and Pardali, Eleni C and Patrikiou, Eleni and Lambrinoudaki, Irene and Goulis, Dimitrios G and Bogdanos, Dimitrios P and Grammatikopoulou, Maria G},
  title = {Fibromyalgia and menopause: Friends with benefits?},
  journal = {Maturitas},
  year = {2026},
  volume = {208},
  pages = {108899},
  doi = {10.1016/j.maturitas.2026.108899}
}
Kostenlos starten →